Evidence map›Paper›PMID 25981402›Full record

Observational studyWorld journal of urology2016

Prognostic factors and outcomes in primary urethral cancer: results from the international collaboration on primary urethral carcinoma.

Georgios Gakis, Todd M Morgan, Jason A Efstathiou, Kirk A Keegan, Johannes Mischinger, Tilman Todenhoefer, Tina Schubert, Harras B Zaid, Jan Hrbacek, Bedeir Ali-El-Dein and 11 more

Abstract readObservational Study
In one paragraph

Observational study in World journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Advanced primary urethral cancer: a case report.Journal of medical case reports · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Georgios GakisDepartment of Urology, University of Tübingen, Tübingen, Germany. georgios.gakis@web.de.
Todd M MorganDepartment of Urology, University of Michigan, Ann Arbor, MI, USA.
Jason A EfstathiouMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kirk A KeeganDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Johannes MischingerDepartment of Urology, University of Tübingen, Tübingen, Germany.
Tilman TodenhoeferDepartment of Urology, University of Tübingen, Tübingen, Germany.
Tina SchubertDepartment of Urology, University of Tübingen, Tübingen, Germany.
Harras B ZaidDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Jan HrbacekDepartment of Urology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Bedeir Ali-El-DeinMansoura Clinic, Urology and Nephrology Center, Mansoura, Egypt.
Rebecca H ClaymanMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Sigolene GallandMassachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kola OlugbadeDepartment of Urology, University of Michigan, Ann Arbor, MI, USA.
Michael RinkDepartment of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Hans-Martin FritscheDepartment of Urology, University Hospital Regensburg, Regensburg, Germany.
Maximilian BurgerDepartment of Urology, University Hospital Regensburg, Regensburg, Germany.
Sam S ChangDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.
Marko BabjukDepartment of Urology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
George N ThalmannDepartment of Urology, University Hospital Berne, Berne, Switzerland.
Arnulf StenzlDepartment of Urology, University of Tübingen, Tübingen, Germany.
Siamak DaneshmandUSC/Norris Comprehensive Cancer Center, Institute of Urology, Los Angeles, CA, USA.

Funding

Vanderbilt Clinical Oncology Research Career Development ProgramK12CA090625 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Debra L. Friedman, Paula Jill Hurley · 2001 to 2026
$16.9M
NCI NIH HHS K12 CA090625
6 · The paper itself

Abstract

purposeTo evaluate risk factors for survival in a large international cohort of patients with primary urethral cancer (PUC).

methodsA series of 154 patients (109 men, 45 women) were diagnosed with PUC in ten referral centers between 1993 and 2012. Kaplan-Meier analysis with log-rank test was used to investigate various potential prognostic factors for recurrence-free (RFS) and overall survival (OS). Multivariate models were constructed to evaluate independent risk factors for recurrence and death.

resultsMedian age at definitive treatment was 66 years (IQR 58-76). Histology was urothelial carcinoma in 72 (47 %), squamous cell carcinoma in 46 (30 %), adenocarcinoma in 17 (11 %), and mixed and other histology in 11 (7 %) and nine (6 %), respectively. A high degree of concordance between clinical and pathologic nodal staging (cN+/cN0 vs. pN+/pN0; p < 0.001) was noted. For clinical nodal staging, the corresponding sensitivity, specificity, and overall accuracy for predicting pathologic nodal stage were 92.8, 92.3, and 92.4 %, respectively. In multivariable Cox-regression analysis for patients staged cM0 at initial diagnosis, RFS was significantly associated with clinical nodal stage (p < 0.001), tumor location (p < 0.001), and age (p = 0.001), whereas clinical nodal stage was the only independent predictor for OS (p = 0.026).

conclusionsThese data suggest that clinical nodal stage is a critical parameter for outcomes in PUC.

Indexed as

AdenocarcinomaAgedAge FactorsCarcinoma, Squamous CellCarcinoma, Transitional CellCohort StudiesDisease-Free SurvivalFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm StagingPrognosisProportional Hazards ModelsRetrospective StudiesClinicalNodal stagePrimary urethral carcinomaPrognosticRisk factorsSurvival

Identifiers

PMID25981402
PMCPMC10176500

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.